SCHEMBL4072291

SCHEMBL4072291

O=C(O)ON1CCC(N2Cc3cscc3NC2=O)CC1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CALCRL Q16602 18/20 0.37
CHRM4 P08173 2/20 0.35
RAMP1 O60894 2/20 0.34
CHRM1 P11229 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4072288 0.84 CALCRL (0.42) CALCRLCHRM4RAMP1
SCHEMBL4083049 0.81 CALCRL (0.50) CALCRLCHRM4RAMP1CHRM1
SCHEMBL4071587 0.78 CALCRL (0.35) CALCRLCHRM4RAMP1CHRM1
SCHEMBL13801333 0.77 CALCRL (0.37) CALCRLCHRM4RAMP1
SCHEMBL3309819 0.76 MAPK1 (0.44) CALCRL
SCHEMBL3277559 0.76 MAPK1 (0.35) CALCRL
SCHEMBL14410188 0.76 MAPK1 (0.43) CALCRLRAMP1
SCHEMBL4074982 0.73 CALCRL (0.48) CALCRLCHRM4RAMP1
SCHEMBL2212650 0.71 CHRM4 (0.50) CALCRLCHRM4RAMP1CHRM1
SCHEMBL4079724 0.68 PDE3B (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2108648-A1 Selected CGRP antagonists, method for their manufacture and use as medicines Boehringer Ingelheim International GmbH (DE) 2009-10-14 EP disclosed
EP-1732917-B1 SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2009-07-29 EP disclosed